Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti - KBR

Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti  KBR

Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E - ...

Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E  Simply Wall St

Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndro...

Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome  Business Wire

Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures - BioSpace

Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures  BioSpace

Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now? - Yahoo Finance

Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now?  Yahoo Finance

Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data d...

Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail  Fierce Biotech

Is Takeda Pharmaceutical Co. (TAK) a Great Value Stock Right Now? - Yahoo Finance

Is Takeda Pharmaceutical Co. (TAK) a Great Value Stock Right Now?  Yahoo Finance

Zydus Licenses Takeda's GERD Drug Vonoprazan for India - Rediffmail

Zydus Licenses Takeda's GERD Drug Vonoprazan for India  Rediffmail

Torrent Pharma inks agreement with Takeda to commercialise novel gastrointestinal drug in India -...

Torrent Pharma inks agreement with Takeda to commercialise novel gastrointestinal drug in India  BSI bureau

Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India - Indian Pharma Post

Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India  Indian Pharma Post

Zydus ties with Takeda to sell GERD drug | Today News - Mint

Zydus ties with Takeda to sell GERD drug | Today News  Mint

Torrent Pharma signs non-exclusive patent agreement with Takeda for its novel drug to treat GERD ...

Torrent Pharma signs non-exclusive patent agreement with Takeda for its novel drug to treat GERD in India  The Financial Express

Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India - Business Standard

Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India  Business Standard

Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in ...

Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in India  Express Pharma

Novel Drug Fails for Two Rare Seizure Disorders - Medpage Today

Novel Drug Fails for Two Rare Seizure Disorders  Medpage Today

Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dre...

Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dream  Fierce Biotech

Takeda signs patent license agreement with Cipla, Sun Pharma to commercialise GERD drug in India ...

Takeda signs patent license agreement with Cipla, Sun Pharma to commercialise GERD drug in India  BSI bureau

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Yahoo Finance

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?  Yahoo Finance

Torrent Pharmaceuticals enters into patent licensing agreement with Takeda - Business Standard

Torrent Pharmaceuticals enters into patent licensing agreement with Takeda  Business Standard

Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Onc...

Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting  Business Wire

FDA and Takeda to Withdraw Mobocertinib for EGFR Exon20+ NSCLC - Targeted Oncology

FDA and Takeda to Withdraw Mobocertinib for EGFR Exon20+ NSCLC  Targeted Oncology

Cipla signs agreement with Takeda to commercialise Vonoprazan - Express Pharma

Cipla signs agreement with Takeda to commercialise Vonoprazan  Express Pharma

Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on t...

Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf  Fierce Biotech

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage ...

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion  StockTitan

Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study - BioSpace

Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study  BioSpace

Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data - Fi...

Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data  Fierce Biotech

Impact of raising the upper extremity siding cardiac implantable electrical devices on postoperat...

Impact of raising the upper extremity siding cardiac implantable electrical devices on postoperative safety  Wiley Online Library

Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another - BioSpace

Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another  BioSpace

Takeda Korea names Peter Trang as head of business operations - KBR

Takeda Korea names Peter Trang as head of business operations  KBR

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Yahoo Finance

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?  Yahoo Finance

FANUC COBOT EASES PAIN FOR TAKEDA PHARMACEUTICAL CO - Process & Control Today

FANUC COBOT EASES PAIN FOR TAKEDA PHARMACEUTICAL CO  Process & Control Today

One Ultra-Cheap High-Yield Dividend Stock to Buy - The Motley Fool

One Ultra-Cheap High-Yield Dividend Stock to Buy  The Motley Fool

Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein–Coupled Receptor 5 ...

Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein–Coupled Receptor 5  Frontiers

CDKL5 Deficiency Disorder Market to Witness Upsurge in Growth, Assesses DelveInsight | Key Compan...

CDKL5 Deficiency Disorder Market to Witness Upsurge in Growth, Assesses DelveInsight | Key Companies in the Market - Jazz, Stoke, Epygenix, Zogenix, UCB Pharma, Takeda, Eisai, Longboard, Marinus  PR Newswire

A Six-Year-Old with a Rare Disease Finds Answers – and Treatment - Direct Relief

A Six-Year-Old with a Rare Disease Finds Answers – and Treatment  Direct Relief

Downregulation of p- COUMAROYL ESTER 3-HYDROXYLASE in rice leads to altered cell wall structures ...

Downregulation of p- COUMAROYL ESTER 3-HYDROXYLASE in rice leads to altered cell wall structures and improves biomass saccharification  Wiley Online Library

Takeda gives Sun Pharma, Cipla rights to commercialise gastro drug in India - ET Manufacturing

Takeda gives Sun Pharma, Cipla rights to commercialise gastro drug in India  ET Manufacturing

Torrent Pharma in pact with Takeda to commercialize acid reflux drug | Company Business News - Mint

Torrent Pharma in pact with Takeda to commercialize acid reflux drug | Company Business News  Mint

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch Phathom Pharmaceuticals -...

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch Phathom Pharmaceuticals  Business Wire

Takeda-Amgen treatment improves survival in metastatic colorectal cancer - BioWorld Online

Takeda-Amgen treatment improves survival in metastatic colorectal cancer  BioWorld Online

Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologi...

Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept  Weill Cornell Medicine Newsroom

Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Per...

Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn’s Disease Patients with Cx601  Business Wire

Torrent Pharma inks pact with Takeda Pharma to commercialise GI drug in India - The Times of India

Torrent Pharma inks pact with Takeda Pharma to commercialise GI drug in India  The Times of India

Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ETHealthWorld

Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India  ETHealthWorld

Mankind Pharma inks pact with Takeda to commercialise acidity drug in India - Business Standard

Mankind Pharma inks pact with Takeda to commercialise acidity drug in India  Business Standard

Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in Ind...

Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India  Express Pharma

Fabrication of Ultra-Thin Printed Organic TFT CMOS Logic Circuits Optimized for Low-Voltage Weara...

Fabrication of Ultra-Thin Printed Organic TFT CMOS Logic Circuits Optimized for Low-Voltage Wearable Sensor Applications  Nature.com

Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in Indi...

Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India  The Financial Express

Loss and Gain: Surviving the 2011 Tohoku Tsunami | Disaster Archipelago: Japan - The Trinity Tripod

Loss and Gain: Surviving the 2011 Tohoku Tsunami | Disaster Archipelago: Japan  The Trinity Tripod